0:00
...
DealMakers: Entrepreneur | Startups | Venture Capital
Description
Lynn Seely started Myovant Sciences which delivers innovative women's health and prostate cancer solutions by efficiently advancing new medicines to market. The company has raised $1 billion from investors such as Danippon Sumitomo Pharma. Myovant Sciences was one of the largest biopharma IPOs in 2016.
In this episode you will learn:
Myovant’s new medical breakthroughs
How Lynn built Myovant’s company culture
Top advice for new founders
Her top tips for female founders and businesswomen
SUBSCRIBE ON:
For a winning deck, take a look at the pitch deck template created by Silicon Valley legend, Peter Thiel (see it here) that I recently covered. Thiel was the first angel investor in Facebook with a $500K check that turned into more than $1 billion in cash.
Moreover, I also provided a commentary on a pitch deck from an Uber competitor that has raised over $400 million (see it here).
Remember to unlock for free the pitch deck template that is being used by founders around the world to raise millions below.
About Lynn Seely:
Lynn Seely is the Chief Executive Officer of Myovant Sciences, a company focused on redefining care for women’s health and prostate cancer. Lynn Seely is an endocrinologist with over 20 years of drug development and biopharmaceutical company leadership experience.
At Medivation, Lynn Seely served as Chief Medical Officer from 2005-2015 and led the development of XTANDI® (enzalutamide) for the treatment of metastatic castration-resistant prostate cancer from IND-enabling studies through to NDA approval and post-approval clinical studies.
Lynn Seely currently serves on the Board of Directors of Blueprint Medicines. Lynn Seely completed her residency in internal medicine at Yale-New Haven Hospital and a basic science and clinical fellowship in endocrinology and metabolism at the University of California, San Diego.
Connect with Lynn Seely:
* Linkedin
* Crunchbase
* * *
FULL TRANSCRIPTION OF THE INTERVIEW:
Alejandro: Alrighty. Hello everyone, and welcome to the DealMakers show. Today we have a founder that I’m super excited to have. I think that we’re going to be learning quite a bit. She’s been involved with many, many different companies, from employee #3 to being the first person that starts the business. I think the journey is remarkable, but I don’t want to wait any longer, and I don’t want to make any of you wait any longer,
In this episode you will learn:
Myovant’s new medical breakthroughs
How Lynn built Myovant’s company culture
Top advice for new founders
Her top tips for female founders and businesswomen
SUBSCRIBE ON:
For a winning deck, take a look at the pitch deck template created by Silicon Valley legend, Peter Thiel (see it here) that I recently covered. Thiel was the first angel investor in Facebook with a $500K check that turned into more than $1 billion in cash.
Moreover, I also provided a commentary on a pitch deck from an Uber competitor that has raised over $400 million (see it here).
Remember to unlock for free the pitch deck template that is being used by founders around the world to raise millions below.
About Lynn Seely:
Lynn Seely is the Chief Executive Officer of Myovant Sciences, a company focused on redefining care for women’s health and prostate cancer. Lynn Seely is an endocrinologist with over 20 years of drug development and biopharmaceutical company leadership experience.
At Medivation, Lynn Seely served as Chief Medical Officer from 2005-2015 and led the development of XTANDI® (enzalutamide) for the treatment of metastatic castration-resistant prostate cancer from IND-enabling studies through to NDA approval and post-approval clinical studies.
Lynn Seely currently serves on the Board of Directors of Blueprint Medicines. Lynn Seely completed her residency in internal medicine at Yale-New Haven Hospital and a basic science and clinical fellowship in endocrinology and metabolism at the University of California, San Diego.
Connect with Lynn Seely:
* Crunchbase
* * *
FULL TRANSCRIPTION OF THE INTERVIEW:
Alejandro: Alrighty. Hello everyone, and welcome to the DealMakers show. Today we have a founder that I’m super excited to have. I think that we’re going to be learning quite a bit. She’s been involved with many, many different companies, from employee #3 to being the first person that starts the business. I think the journey is remarkable, but I don’t want to wait any longer, and I don’t want to make any of you wait any longer,